Ganga Pharmaceuticals Limited (BOM:539680)
India flag India · Delayed Price · Currency is INR
12.00
0.00 (0.00%)
At close: Feb 12, 2026

Ganga Pharmaceuticals Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Revenue
28.2826.3727.3625.8624.89
Other Revenue
---0--
28.2826.3727.3625.8624.89
Revenue Growth (YoY)
7.22%-3.60%5.78%3.91%4.83%
Cost of Revenue
13.0312.1912.5112.4912.92
Gross Profit
15.2514.1814.8513.3811.97
Selling, General & Admin
14.855.925.915.215.12
Other Operating Expenses
-9.428.378.136.43
Operating Expenses
15.4115.8114.7713.8912.1
Operating Income
-0.17-1.630.08-0.51-0.13
Interest Expense
-1.33-1.69-1.81-1.87-1.9
Interest & Investment Income
-2.482.392.982.59
Other Non Operating Income (Expenses)
2.79-0.1-0.04-0.07-0.04
EBT Excluding Unusual Items
1.29-0.930.630.530.51
Gain (Loss) on Sale of Assets
-1.88---
Pretax Income
1.290.950.630.530.51
Income Tax Expense
0.280.160.170.140.13
Net Income
1.020.790.470.390.38
Net Income to Common
1.020.790.470.390.38
Net Income Growth
28.44%69.52%18.60%3.74%86.16%
Shares Outstanding (Basic)
65544
Shares Outstanding (Diluted)
67744
Shares Change (YoY)
-9.69%-62.79%--
EPS (Basic)
0.170.160.100.100.09
EPS (Diluted)
0.170.120.070.100.09
EPS Growth
41.67%71.43%-27.67%7.53%80.00%
Free Cash Flow
-13.48-6.76-12.86-0.55-2.25
Free Cash Flow Per Share
-2.26-1.02-1.95-0.14-0.56
Gross Margin
53.91%53.78%54.29%51.73%48.10%
Operating Margin
-0.59%-6.17%0.31%-1.99%-0.51%
Profit Margin
3.59%3.00%1.70%1.52%1.52%
Free Cash Flow Margin
-47.65%-25.63%-47.02%-2.11%-9.06%
EBITDA
0.39-1.160.580.050.42
EBITDA Margin
1.38%-4.41%2.11%0.18%1.69%
D&A For EBITDA
0.560.470.490.560.55
EBIT
-0.17-1.630.08-0.51-0.13
EBIT Margin
-0.59%-6.17%0.31%-1.99%-0.51%
Effective Tax Rate
21.50%16.55%26.33%26.01%26.00%
Revenue as Reported
31.0730.7329.7528.8527.48
Advertising Expenses
-0.150.110.10.13
Source: S&P Global Market Intelligence. Standard template. Financial Sources.